Drawing for IXP-RAPID

USPTO serial 79180324

IXP-RAPID

Reviewed by CopyMark Law Group

Reg. 5262886Status 404
Filing date
Status date
Registration date
Aug 15, 2017
Examiner
LEE, JEANIE H
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IXP-RAPID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leigh Ann Lindquist

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC2100 PENNSYLVANIA AVE, NW SUITE 800WASHINGTON, DC 20037UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for treating systemic inflammation associated with infection; Clinical diagnostic reagents for medical or veterinary use, namely, medical diagnostic reagents not for laboratory use; biological and chemical test reagents for clinical and medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disordersSECTION 71 - CANCELLED—
010Surgical and medical apparatus and instruments for use in analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infection; Medical diagnostic testing apparatus for carrying out diagnostic tests particularly for the analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infection; diagnostic test apparatus in this class consisting primarily of probes, buffers and reagents for use in microbial testing for medical purposes; Point of care medical devices, namely, devices for analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infectionSECTION 71 - CANCELLED—
044Medical services; Medical services in the field of pathology; Medical and pathology services being the analysis of body fluid samples, namely, medical testing for diagnostic or treatment purposes; medical services being molecular diagnostic services; Medical services, namely, taking of body fluid samples of others; information, advisory and consultancy services in relation to the aforementionedSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 9, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Apr 9, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 14, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Nov 21, 2024INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 21, 2024INPCINVALIDATION PROCESSED—
Nov 2, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 1, 2024C71TCANCELLED SECTION 71—
Aug 15, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 26, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 5, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 5, 2017FIMPFINAL DISPOSITION PROCESSED—
Nov 15, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 15, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 28, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 23, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 7, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 7, 2017OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 30, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 30, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2017GPNXNOTIFICATION PROCESSED BY IB—
May 18, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 10, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 10, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 10, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 21, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 13, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 4, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 28, 2017PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 10, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 4, 2017ALIEASSIGNED TO LIE—
Feb 23, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 23, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Feb 23, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 23, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 23, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 10, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 16, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 2, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 2, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 2, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 5, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 5, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2016ALIEASSIGNED TO LIE—
Jul 20, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 19, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 19, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2016RFNTREFUSAL PROCESSED BY IB—
Jan 19, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 19, 2016RFRRREFUSAL PROCESSED BY MPU—
Jan 15, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 14, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 9, 2016DOCKASSIGNED TO EXAMINER—
Jan 9, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 7, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance